Fresh Tracks Therapeutics (NASDAQ:FRTX) Stock Price Down 0.3% – Here’s Why

Shares of Fresh Tracks Therapeutics, Inc. (NASDAQ:FRTXGet Free Report) traded down 0.3% during mid-day trading on Monday . The company traded as low as $0.93 and last traded at $0.93. 1,328 shares traded hands during trading, a decline of 51% from the average session volume of 2,735 shares. The stock had previously closed at $0.93.

Fresh Tracks Therapeutics Stock Down 0.5 %

The company has a 50 day simple moving average of $0.78 and a 200 day simple moving average of $0.77. The company has a market capitalization of $5.52 million, a price-to-earnings ratio of -0.66 and a beta of 0.54.

Fresh Tracks Therapeutics Company Profile

(Get Free Report)

Fresh Tracks Therapeutics, Inc does not have significant operations. Previously, the company was engaged in the development of various prescription therapeutics for the treatment of autoimmune, inflammatory, and other debilitating diseases in the United States. Fresh Tracks Therapeutics, Inc was founded in 2009 and is headquartered in Boulder, Colorado.

Read More

Receive News & Ratings for Fresh Tracks Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresh Tracks Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.